Bond Screener
Roche Holding AG
LEI 549300U41AUUVOAAOB37, SWIFT ROCHCHBHXXX
Organization name
Roche Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
6,279 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases. The company is also involved in the provision of pharmaceutical products for various therapeutic areas comprising oncology, virology, inflammation, metabolic disorders, and central nervous system. In addition, it offers a portfolio of diagnostics products, such as blood glucose meters for diabetes patients; point-of-care testing devices for use in doctors offices; high-throughput analyzers for hospitals and commercial diagnostic laboratories; and start-of-the-art instruments and reagents for life science research.
|
General information
-
Organization nameRoche Holding AG
-
Organization statusOperating organization
-
AddressGrenzacherstr. 124 Basel, Switzerland, 4058
-
Site
-
IR Site
News
-
Rogers Corporation (NYSE:ROG) Q2 2026 Earnings: Mixed Financial Results and Key Insights29/07/2026
-
Roche Holding AG's Financial Performance and Outlook29/01/2026
-
New issues: Roche Holding AG issued international bonds (USU75000CT18, USU75000CV63) in the amount of USD 500, USD 800 mln maturing in 2030, 2035 respectively.26/11/2025
-
DuPont Strengthens Global RO Reach With China Facility Acquisition07/10/2025
-
DuPont Strengthens Global RO Reach With China Facility Acquisition07/10/2025
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameRoche Holding AG
-
Organization statusOperating organization
-
AddressGrenzacherstr. 124 Basel, Switzerland, 4058
-
Site
-
IR Site
Codes
-
LEI549300U41AUUVOAAOB37
-
SWIFTROCHCHBHXXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000896566
-
UIDCHE101602521
